Antiviral drug abandoned by pharma shows promise against dengue
A daily pill can prevent the crippling disease, but its maker won’t bring it to market
A daily pill can prevent the crippling disease, but its maker won’t bring it to market
A daily pill can prevent the crippling disease, but its maker won’t bring it to market
Prophylactic use of azithromycin saves vulnerable children’s lives, but could trigger antibiotic resistance
FDA to approve leucovorin despite questions about whom it might help
Aedes aegypti further adapted to life around humans when it arrived in the Americas, study of hundreds of mosquito genomes reveals